← Eichor
Study identifier: NCT06883864 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgiTation and pErsistent Atrial Fibrillation: a Randomized Controlled Trial

Condition: Atrial Fibrillation (AF) · Catheter Ablation · Atrial Functional Mitral Regurgitation  ·  Sponsor: Beijing Anzhen Hospital

PhaseNA
Planned participants146
Who can joinAll sexes, 18 Years to 80 Years
Healthy volunteersNo

About this study

Atrial fibrillation (AF) leads to atrial functional mitral regurgitation (MR) through mechanisms including mitral annular dilatation, systolic leaflet motion distance alteration, and contractility decrease. Compared with primary MR, atrial functional MR due to AF and other diseases tends to have a worse prognosis, with a higher risk of death and heart failure hospitalization. MR and AF co-exist and exacerbate left atrial dysfunction, further causing worse cardiac dysfunction, valvular regurgitation, and aggravating prognosis. The best therapy for secondary MR is unclear because MR is only one component of the disease, and restoration of mitral valve competence is not curative. Catheter ablation improves symptoms and cardiac function in patients with AF, reduces risks of AF recurrence and hospitalization, as well as increases quality of life. For patients with AF combined with functional moderate-to-severe MR, previous observational studies have found that the severity of MR significantly reduced after taking catheter ablation to restore sinus rhythm. We hypothesized that catheter ablation would significantly improve the severity of MR in patients with severe atrial functional MR combined with persistent AF compared with drug therapy alone.

This description comes directly from the study's public registry record.

Talk to the study team

liu HE, MD  ·  +86 13810720787  ·  theliu@139.com

Caihua Sang, MD

Always discuss trial participation with your own doctor first.

Locations (17)

The First Affiliated Hospital of Anhui Medical UniversityHefei, Anhui, ChinaRecruiting
Beijing Anzhen Hospital, Capital Medical UniversityBeijing, Beijing Municipality, ChinaRecruiting
Peking University Third HospitalBeijing, Beijing Municipality, ChinaRecruiting
Xiamen University Affiliated Cardiovascular HospitalXiamen, Fujian, ChinaNot Yet Recruiting
Guangdong Provincial People's HospitalGuangzhou, Guangdong, ChinaNot Yet Recruiting
The Second Hospital of Hebeimedical UniversityShijiazhuang, Hebei, ChinaRecruiting
The First Affiliated Hospital of Harbin Medical UniversityHarbin, Heilongjiang, ChinaRecruiting
The Second Affiliated Hospital of Harbin Medical UniversityHarbin, Heilongjiang, ChinaRecruiting
The First Affiliated Hospital of Zhengzhou UniversityZhengzhou, Henan, ChinaNot Yet Recruiting
Wuhan Asia Heart HospitalWuhan, Hubei, ChinaRecruiting
Tongji Hospital Affiliated to Tongji Medical College of Huazhong University of Science and TechnologyWuhan, Hubei, ChinaRecruiting
The first hospital of Jilin UniversityChangchun, Jilin, ChinaNot Yet Recruiting

+ 5 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06883864